课题基金 / 基金详情

Investigation of correlation between pulmonary fibrosis and carcinogenesis : Analysis about expression of p53, CD44 and nitric oxide synthase(NOS).

Investigation of correlation between pulmonary fibrosis and carcinogenesis : Analysis about expression of p53, CD44 and nitric oxide synthase(NOS).
肺纤维化与癌变相关性研究:p53、CD44、一氧化氮合酶(NOS)表达分析。
批准号:
10670552
负责人:
MATSUMOTO Mitsuhiro
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000

项目摘要

项目成果

MATSUMOTO Mitsuhiro的其他基金

相似基金

相关文献

中文摘要
翻译
我们检测了抑癌基因(P53)、黏附分子(CD44亚型)和致癌产物(一氧化氮合酶(NOS))的表达,以探讨肺纤维化与癌变的关系。(1)抑癌基因P53在肺癌组织、纤维化组织和非肿瘤组织中的表达状况:我们用酵母P53功能检测系统检测了P53的功能。我们发现63%的检测样本发生了P53突变(Int J Oncol.,12;525-533,1998)。(2)肺癌组织、肺纤维化组织和非肿瘤组织中黏附分子CD44亚型的表达:我们认为可以根据CD44亚型比值的变化来判断标本的恶性程度(J Natl Cancer Inst.,90;307-315,1998…更多)。此外,CD44的裂解在细胞迁移过程中有效地从透明质酸底物上分离起关键作用,从而促进CD44介导的癌细胞迁移(癌基因18;1435-46,1999年)以及Rho家族蛋白在调节CD44的分布和裂解中发挥作用(J BC C.,274;25525-34,1999)。(3)肺组织中一氧化氮合酶(NOS)表达与P53突变的相关性:一氧化氮(NO)可诱导P53抑癌基因突变,因此我们分析了早期肺腺癌中一氧化氮合酶(NOS)活性与P53基因状态的关系。NO具有潜在的致突变和致癌活性,并可能在人类肺腺癌中发挥重要作用(Jpn J癌症研究,89;696-702,1998)。然而,一氧化氮合酶的表达水平并不稳定,我们不能证实bNOS在纤维化病变中的高表达。提示P53突变、CD44亚型和NOS在不同癌变组织中的表达具有异质性。较少
英文摘要
We examined expressions of tumor suppressor gene(p53), adhesion molecules(CD44 isoforms) and carcinogenic products(nitric oxide synthase : NOS) to investigate about correlation between pulomonary firosis and carcinogenesis.(1) Status of tumor suppressor gene p53 expression in lung cancer tissue, fibrotic tissue and non-tumorous tissue : We used an system of yeast p53 functional assay to examine an function of p53. We difined that p53 mutation occurred 63% of examined samples drived from primary lung cancer tissue(Int J Oncol., 12 ; 525-533, 1998). On the other hand, we could not comfirm that p53 mutation significantly occurred examined samples drived from pulmonary fibrosis tissue and also non-tumorous lung tissue.(2) Expression of adhesion molecules CD44 isoforms in lung cancer tissue, fibrotic tissue and non-tumorous tissue : We suggested that we could diagnosed whether sample specimens were malignancy or not from changes of CD44 isoforms ratio(J Natl Cancer Inst., 90 ; 307-315, 1998 … More ). Furthermore, CD44 cleavage plays a critical role in an efficient cell-detachment from a hyaluronate substrate during the cell migration and consequently promotes CD44-mediated cancer cell migration.(Oncogene.18 ; 1435-46, 1999) and also the Rho family proteins play a role in regulation of CD44 distribution and cleavage(J B C., 274 ; 25525-34, 1999). We could not find out any differences in fibrous lesions and also non-tumorous lesion about expressions of CD44 isoforms pattern.(3) Correlation between expressions of nitric oxide synthase(NOS) and p53 mutations in lung tissues : NO(nitric oxide) induces mutation in the p53 tumor suppressor gene ; we therefore analyzed the relationship between NO synthase(NOS) activity and p53 gene status in early-stage lung adenocarcinoma. NO has potential mutagenic and carcinogenic activity, and may play important roles in human lung adenocarcinoma(Jpn J Cancer Res., 89 ; 696-702, 1998). However, levels of NOS expression were unstable and we couldn't confirm high expression of bNOS in fibrotic lesions. We suggested that expressions of p53 mutation, CD44 isoforms and NOS were heterogeneous different from cancerous lesions. Less
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
J.Sasaki, H.Miyake, M.Matsumoto, M.Suga, M.Ando and H.Saya.: "Expression of CD44 splicing isoforms in lung carcers"International Journal of Oncology. 12. 525-533 (1998)
J.Sasaki、H.Miyake、M.Matsumoto、M.Suga、M.Ando 和 H.Saya.:“CD44 剪接亚型在肺癌中的表达”国际肿瘤学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Eto H. Yoon SS. Bode BP. Kamidono S. Makino K. Saya et al.: "Mapping and regulation of the tumor-associated epitope recognized by monoclonal antibody RS-11."Journal of Biological Chemistry.. 275・35. 27075-27085 (2000)
Eto H. Yoon SS. Bode BP. Kamidono S. Makino K. Saya 等:“单克隆抗体 RS-11 识别的肿瘤相关表位的定位和调节”。《生物化学杂志》275・35。 -27085 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 25 条
    Investigation of quasi two-dimensional fluid phase change and its application to cleansing of laminated plates
    • 批准号:
      15K05826
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2015
    • 负责人:
      MATSUMOTO Mitsuhiro
    • 依托单位:
    Modeling of Thermophysical Properties and Heat Transfer for Solids with Nano-scale Structure
    • 批准号:
      19560205
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2007
    • 负责人:
      MATSUMOTO Mitsuhiro
    • 依托单位:
    Development of dosage individualization of anti-tumor drugs based on therapeutic drug monitoring and pharmacokinetic-related gene expression
    • 批准号:
      17590131
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2005
    • 负责人:
      MATSUMOTO Mitsuhiro
    • 依托单位:
    NANO-SCALE MODELING OF SOLID HEAT CONDUCTION FOR WIDE-GAP SEMICONDUCTOR DEVICES
    • 批准号:
      17560185
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2005
    • 负责人:
      MATSUMOTO Mitsuhiro
    • 依托单位:
    国内基金
    海外基金
    Circ_0001313/miR-338-3p经P53调控铁死亡降低结直肠癌放化疗敏感性的机制
    基于影像组学与代谢组学特征图谱的机器学习模型在P53突变型子宫内膜癌中的临床应用研究
    • 批准号:
      2026JJ82384
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      颜志鹏
    • 依托单位:
    APR-246靶向突变p53通路逆转DLBCL耐药的分子功能及机制研究
    • 批准号:
      JCZRQNB202600696
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    黄芩素通过p53信号通路逆转胃黏膜肠上皮化生的机制研究